SCHEMBL10486079

SCHEMBL10486079

CCCCCCC1CCC(C2CCC(OC)CC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.41
▸ HTT P42858 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ EPHX1 P07099 1/20 0.37
▸ SPHK1 Q9NYA1 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ LSS P48449 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ DAO P14920 1/20 0.35
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ NAAA Q02083 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ GNAO1 P09471 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10703267 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10486083 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10486456 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10704675 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10708259 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10702793 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10486036 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10485965 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10486301 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1
SCHEMBL10486028 1.00 CYP1A2 (0.41) CYP1A2HTTMEN1KMT2AEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element JNC CORPORATION (JP) 2019-08-27 — — US disclosed
US-4868341-A LIQUID CRYSTALS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-09-19 — — US disclosed
US-4622164-A LIQUID CRYSTAL DIELECTRICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element SP1, HVCN1, CXCR1 CYP1A2 2616/4885HTT 4549/4885MEN1 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback